In 2023, Japan's government expenditure on R&D in health was recorded at $1.67 billion US dollars PPP, constant. The forecasted data reveals a consistent increase in investment from 2024 through 2028, starting at $1.72 billion in 2024 and expected to reach $1.89 billion by 2028. This indicates an average annual growth rate (CAGR) of approximately 2.5% over the five-year forecast period.
Trends and Variations:
- 2024-2025: 2.9% growth
- 2025-2026: 2.3% growth
- 2026-2027: 2.2% growth
- 2027-2028: 2.2% growth
- 5-Year CAGR: 2.5%
Future Trends to Watch:
The continuous investment growth in R&D is likely driven by Japan’s focus on health innovation and aging population challenges. Monitoring government policy changes, potential increases in private sector collaborations, and advancements in biotechnology and AI will be crucial for understanding future expenditure dynamics.
